Health Sensors Market Size, Share & Trends Analysis Report By Application (Wellness Monitoring, Chronic Illness & At Risk-Monitoring), By Product (Implantable/Ingestible, Wearable)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

The global Health Sensors market size was estimated at USD 41.28 billion in 2021 and is expected to surpass around USD 142.58 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 19.13% during the forecast period 2022 to 2030.

Key Takeaways:

• By Application, the U.S. Health Sensors market was valued at USD 3.9 Billion in 2021 and expected to witness growth at a CAGR of 20.8% from 2022 to 2030.
• The wearable health sensors allow for long-term patient monitoring and care at home for COVID-19 patients
• They have also demonstrated the potential to have a substantial impact in a number of ways on the data that are accessible for clinical trials & medical researchers
• For instance, Honeywell unveiled a new wearable device in May 2018 that enables its employees to obtain trustworthy information in real time and is expected to improve the efficiency and safety of the workplace
• The chronic illness & at risk-monitoring application segment dominated the market in 2021 due to the increased prevalence of chronic disorders and awareness regarding advanced products
• The wearable sensors product segment accounted for the maximum revenue share in 2021 due to advanced features of these products, such as ability to monitor vital parameters like heart rate and blood pressure. Moreover, these devices are highly accurate, durable, and reliable
• Asia Pacific is estimated to register the highest CAGR over the forecast period. Increasing disposable income, growing awareness levels, and rising incidence rate of chronic conditions are few factors promoting the region’s growth

The market is expected to grow due to the increasing geriatric population, growing inclination towards fitness, and increasing prevalence of chronic diseases. In the current complex healthcare environment, the need for advanced and accurate monitoring systems increases as healthcare organizations progress to provide better services. Health sensors is continuously evolving from ad-hoc to continuous monitoring to provide accurate data to clinicians to make treatment decisions.

The main focus of hospitals and healthcare providers is to get reliable data and lower-cost devices, which is considered the first step toward technological advancement. Moreover, technological advancements in health sensors devices can support clinicians in identifying patients with high risk of disease, which is anticipated to spur industry growth. For instance, in January 2021, Biosticker is a highly on-body advanced sensor that allows effortless monitoring of vital signs and actionable insights provided to clinicians from patients in hospitals or homecare settings, which can create a unique opportunity for the early detection of complications. As a result of this, the industry is expected to grow.

The COVID-19 outbreak is expected to have a positive impact on the overall industry. This is due the factors, such as high product demand to remotely monitor the health status of patients infected with coronavirus or self-quarantined individuals taking treatment in a personal room, to reduce the transmission rate of COVID-19 infectious among the caregivers, surgeons, patients of other diseases, and hospital management personnel as wearable technology enables the caregivers & surgeons to check patients in real-time, and others. The coronavirus outbreak has also compelled a complete reassessment of clinical trial design. The use of wearables in decentralized clinical trials is one area with significant potential (DCTs).

Report Scope of the Health Sensors Market

Application Insights

The chronic illness & at-risk-monitoring segment led the global industry in 2021 and accounted for the largest share of more than 23.30% of the overall revenue. This is due to the increasing prevalence of chronic diseases and the demand for point-of-care testing. Chronic diseases, such as diabetes, need monitoring to check the progression as well as the regression of the disease in patients. Thus, several devices designed to track activities as well as monitor the risks associated with the health of patients are available. For instance, in June 2020, the integrated Continuous Glucose Monitoring (iCGM) FreeStyle Libre 2 system from Abbott was approved by the U.S. FDA. This device makes it possible to monitor glucose levels in adults and children (aged 4 years & above) in real-time.

Furthermore, the system was offered at the same price as that of the FreeStyle Libre 14-day system, which is nearly one-third the cost of other continuous glucose monitors. Quantum Operation, Inc., a Tokyo-based startup, introduced a wearable noninvasive continuous blood glucose monitor at the 2021 CES. Thus, the introduction of such innovative and affordable systems is expected to positively impact segment growth. Wellness monitoring is the second-leading segment after chronic illness & at risk-monitoring. Wellness monitoring involves tracking healthcare indicators and digitally monitoring using devices, such as Fitbit products and Apple Watch.

Fitbit uses a three-dimensional accelerometer system that helps track motion as well as the intensity of that motion. Fitbit’s algorithm is designed to convert raw accelerometer data to relevant information as well as to check the calories burned by users and the soundness of their sleep. This algorithm is also used to track the heart rate of patients. For instance, in April 2022, Fitbit’s new PPG (photoplethysmography) algorithm to detect Atrial Fibrillation (AFib)was approved by the U.S. FDA. The technology will power Fitbit’s new function for irregular heart rhythm notifications. The different data points gathered from Fitbit devices are anticipated to be used by several cancer research institutions to monitor patients.

As a result of such advancements, the industry is expected to grow. Wearable technologies are rapidly extending their reach and evolving to provide solutions for healthcare and wellness. In 2022, at an event called “CES 2022: A Digital Health Showcase”, companies in the MedTech industry showcased their new range of wellness and health devices. Moreover, in September 2020, the I Libre Sense Glucose, a sport biosensor, was introduced by Abbott. The device is made specifically for athletes to help them better understand how their blood glucose levels and physical performance are related. Libre Sense is a biosensor based on Abbott’s FreeStyle Libre continuous glucose monitoring technology.

Product Insights

In 2021, the wearable sensors product segment dominated the industry and accounted for the largest share of more than 41.20% of the overall revenue. Wearable sensors enable devices to monitor patients’ physiological and motion activities. These sensors can be embedded in clothing, shoes, wristbands, and headbands, or attached directly to the body. These devices are used to track, monitor, and record various healthcare indicators, such as pulse, blood pressure, heart rate, calorie intake, etc. These devices can also be used in long-term monitoring, and with increasing penetration & application of big data analytics, they are being used to predict & prevent any medical emergency.

Thus, due to the various advantages of wearable sensors, the demand for these devices is anticipated to increase over the forecast period. Increasing R&D investment and collaborations between companies are also expected to propel industry growth. For instance, in March 2022, a provider in healthcare technology and a global provider of communications solutions and photonics-based health monitoring, Rockley Photonics Holdings Ltd., recently announced its decision to cooperate with Medtronic on new projects. The two companies intend to collaborate to use Rockley’s recently released Bioptx biomarker sensing technology along with Medtronic’s solutions in a variety of healthcare contexts.

By possibly providing real-time, round-the-clock, non-invasive monitoring of a person’s well-being and health, the cooperation with Medtronic builds on the social shift from reactive to proactive healthcare, enabling physicians to personalize care with actionable data. The implantable/ingestible sensors segment is projected to expand at the fastest CAGR during the forecast period. Ingestible/implantable sensors are highly accurate, miniaturized, and completely safe. These sensors are used to provide localized drug delivery, deep brain stimulation, heart stimulation, and bladder stimulation.

Regional Insights

North America dominated the global industry in 2021 and accounted for the largest share of over 36.10% of the overall revenue. This can be attributed to its well-established healthcare infrastructure, high healthcare expenditure, presence of dominant players, and rapid adoption of advanced technologies. North America has the most developed health sensors sector globally. The rapid adoption of patient monitoring & homecare devices for regular, continuous, and long-term monitoring of patients & reducing the frequency of hospital visits are anticipated to fuel the region’s growth over the forecast period. Favorable reimbursement structures are expected to further fuel the region’s growth.

Other factors likely to boost the growth include the increasing prevalence of lifestyle-associated health conditions, accidents, and sports injuries. Growing demand for effective emergency care and increasing adoption of mobile surgery centers are expected to drive the industry during the forecast period. Furthermore, the COVID-19 pandemic has increased the requirement for health sensor devices, as patients opted for homecare treatment to avoid the risk of infection. As per a survey conducted by Insider Intelligence, 23.4 million patients in the U.S. used Remote Patient Monitoring (RPM) tools and services in 2020, and as per the same source, 30 million U.S. patients, or 12.2% of the population, will use RPM tools by 2024.

The FDA issued Emergency Use Authorizations (EUAs) for certain wearable and patient monitoring devices to increase the availability of treatments & monitoring of patients and help reduce exposure of SARS-CoV-2 to healthcare providers during the pandemic. Asia Pacific is expected to register the fastest growth in the global industry during the forecast period. The rising incidence of cardiac diseases has created a demand for health sensor equipment in APAC countries. Furthermore, with some of the highest diabetes rates in the world, India and China have been the most afflicted countries. In the South-East Asia (SEA) Region of the IDF, 90 million persons (20-79) suffered from diabetes in 2021, according to The International Diabetes Federation (IDF) estimates.

By 2030 and 2045, this number is projected to rise to 114 million and 156 million, respectively. According to the Indian Journal of Ophthalmology, globally and in emerging nations like India, the burden of diabetes is huge and rising, primarily due to increasing cases of overweight/obesity and unhealthy lifestyles. In India, 77 Mn people were estimated to have diabetes in 2019, and by 2045, that number is projected to reach over 134 million. As a result, the region is seeing an increase in demand for home-based health sensors, which is opening up new growth opportunities. Furthermore, the region is home to a number of major companies, which helps boost its share.

Some of the prominent players in the Health Sensors Market include:

• Analog Devices Inc.
• Avago Technologies Ltd.
• Danaher Corp.
• GE Healthcare
• Honeywell International Inc.
• Medtronic Plc.
• Smith’s Medical Inc.
• Koninklijke Philips
• Sensirion AG
• Stryker Corp.
• Abbott Laboratories
• Roche
• Hologic
• Varian Medical System

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Health Sensors market

• Application
• Chronic Illness & At Risk-Monitoring
• Wellness Monitoring
• Patient Admission Triage
• Logistical Tracking
• In Hospital Clinical Monitoring
• Sensor Therapeutics
• Post-Acute Care Monitoring

• Home-based
• Others
• Product
• Hand Held Diagnostic Sensors
• Chronic Illness & At Risk-monitoring
• Patient Admission Triage
• Logistical Tracking
• In-hospital Clinical Monitoring
• Post-acute Care Monitoring
• Wearable Sensors
• Disposable Wearable Sensors
• Non-disposable Wearable Sensors

• Wellness Monitoring
• Chronic Illness & At Risk-monitoring
• Patient Admission Triage
• Logistical Tracking
• In-hospital Clinical Monitoring
• Sensor Therapeutics
• Post-acute Care Monitoring
• Implantable/Ingestible Sensors
• Wellness Monitoring
• Chronic Illness & At Risk-monitoring
• Patient Admission Triage
• In-hospital Clinical Monitoring
• Sensor Therapeutics
• Post-acute Care Monitoring

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Health Sensors industry analysis from 2022 to 2030 to identify the prevailing Health Sensors industry opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the global Health Sensors industry segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global Health Sensors industry trends, key players, market segments, application areas, and market growth strategies.